| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 59025 |
Fetal non-stress test |
949 |
646 |
$298K |
| 36415 |
Collection of venous blood by venipuncture |
7,354 |
6,323 |
$196K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,238 |
3,950 |
$194K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,080 |
979 |
$110K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
699 |
606 |
$95K |
| 80053 |
Comprehensive metabolic panel |
1,181 |
1,056 |
$83K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
705 |
652 |
$73K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,042 |
1,781 |
$65K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
658 |
593 |
$48K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
48 |
43 |
$36K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
274 |
269 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
75 |
74 |
$15K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
16 |
13 |
$15K |
| 95806 |
|
85 |
81 |
$13K |
| 86140 |
|
546 |
489 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
322 |
301 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
322 |
301 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
253 |
242 |
$8K |
| 81003 |
|
655 |
443 |
$7K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
45 |
40 |
$6K |
| 81001 |
|
281 |
232 |
$6K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
40 |
25 |
$5K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
137 |
134 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
189 |
154 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
336 |
304 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
55 |
50 |
$4K |
| 87210 |
|
160 |
148 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
15 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
19 |
17 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
118 |
112 |
$3K |
| 94060 |
|
13 |
12 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
12 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
42 |
37 |
$2K |
| 85027 |
|
59 |
57 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
14 |
14 |
$2K |
| 86710 |
|
18 |
17 |
$2K |
| 80061 |
Lipid panel |
27 |
27 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
61 |
56 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15 |
12 |
$1K |
| 83605 |
|
26 |
25 |
$1K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
80 |
75 |
$814.65 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
13 |
$628.94 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
13 |
12 |
$554.79 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
16 |
15 |
$526.15 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
12 |
$520.20 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
20 |
12 |
$342.51 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
33 |
12 |
$321.79 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
32 |
24 |
$310.05 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$258.60 |
| 86803 |
|
12 |
12 |
$250.90 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
29 |
25 |
$205.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21 |
14 |
$193.68 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$157.90 |
| J2704 |
Injection, propofol, 10 mg |
15 |
14 |
$155.11 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
12 |
12 |
$19.84 |